Medical notice: Educational content only. CanduCardio is intended for healthcare professionals and CanduTV for the general public. It does not replace clinical judgment or professional consultation.
Therapy group: P2Y12 inhibitors · Therapy: Prasugrel vs ticagrelor
In acute coronary syndromes managed invasively, prasugrel lowered death, myocardial infarction or stroke compared with ticagrelor, without significantly increasing major bleeding.
Published in N Engl J Med (2019)
Card generated automatically with AI from the abstract of the original publication and the trial registry; every figure was checked against those sources. It may contain errors: verify the data at the source before using it for clinical decisions.
Generated on October 14, 2026
Educational content only. CanduCardio is intended for healthcare professionals and CanduTV for the general public. It does not replace clinical judgment or professional consultation.